FR2357543A1 - Procede pour l'obtention de 2-azetidinone 1,3-disubstituee, utile comme antibiotique - Google Patents

Procede pour l'obtention de 2-azetidinone 1,3-disubstituee, utile comme antibiotique

Info

Publication number
FR2357543A1
FR2357543A1 FR7700069A FR7700069A FR2357543A1 FR 2357543 A1 FR2357543 A1 FR 2357543A1 FR 7700069 A FR7700069 A FR 7700069A FR 7700069 A FR7700069 A FR 7700069A FR 2357543 A1 FR2357543 A1 FR 2357543A1
Authority
FR
France
Prior art keywords
substd
opt
haloalkyl
arylthio
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7700069A
Other languages
English (en)
Other versions
FR2357543B1 (fr
Inventor
Takashi Kamiya
Masashi Hashimoto
Osamu Nakaguti
Teruo Oku
Yoshiharu Nakai
Hidekazu Takeno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2357543A1 publication Critical patent/FR2357543A1/fr
Application granted granted Critical
Publication of FR2357543B1 publication Critical patent/FR2357543B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/04—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procédé pour l'obtention d'un composé de formule :
FR7700069A 1976-01-05 1977-01-04 Procede pour l'obtention de 2-azetidinone 1,3-disubstituee, utile comme antibiotique Granted FR2357543A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24276 1976-01-05

Publications (2)

Publication Number Publication Date
FR2357543A1 true FR2357543A1 (fr) 1978-02-03
FR2357543B1 FR2357543B1 (fr) 1979-08-24

Family

ID=9700935

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7700069A Granted FR2357543A1 (fr) 1976-01-05 1977-01-04 Procede pour l'obtention de 2-azetidinone 1,3-disubstituee, utile comme antibiotique

Country Status (4)

Country Link
JP (1) JPS52106857A (fr)
BE (1) BE850085A (fr)
DE (1) DE2700178A1 (fr)
FR (1) FR2357543A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389695B (de) * 1981-10-23 1990-01-10 Roussel Uclaf Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonderivaten
JPS60139667A (ja) * 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
GB8503193D0 (en) * 1985-02-08 1985-03-13 Shell Int Research Azetidine derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
FR2357543B1 (fr) 1979-08-24
DE2700178A1 (de) 1977-07-14
JPS613785B2 (fr) 1986-02-04
BE850085A (fr) 1977-07-04
JPS52106857A (en) 1977-09-07

Similar Documents

Publication Publication Date Title
ES8101596A1 (es) Metodo para producir compuestos de beta-lactama
DE3881468D1 (de) Heterocyclisch substituierte azole und azine, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung.
FR2334349A1 (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
ES454169A0 (es) Procedimiento para la produccion de capas de recubrimiento endurecidas a partir de una mezcla de revestimiento en forma de polvo altamente reactiva.
PL327748A1 (en) Novel benzimidazole, benzoxazole and benzothiazole compounds, method of obtaining them and pharmaceutic compositions containing such compounds
ES299038A1 (es) Procedimiento de preparaciën de nuevas penicilinas
FR2357543A1 (fr) Procede pour l'obtention de 2-azetidinone 1,3-disubstituee, utile comme antibiotique
FR2335212A2 (fr) Azetidinones et procede pour leur preparation
FR2384747A1 (fr) Imines et procede pour leur preparation
NL7613973A (en) Antibacterial azetidinones with a carboxyalk(en)yl side chain - prepd. e.g. by acylation and cyclisation of imines
ES476856A1 (es) Procedimiento para la obtencion de derivados de acidos aza- biciclo-3,2-0 carboxilicos.
NZ504316A (en) Pyrimidine substituted carboxylic acid derivatives which have amido side-chains useful as endothelin receptor antagonists
FR2392996A1 (fr) Agent antibacterien a cycle b-lactame utilisable comme medicament
ES8403108A1 (es) Un procedimiento para preparar azetidinas.
FI885544A0 (fi) Nya foereningar.
SE7908024L (sv) Heterocykliska foreningar
FI823199A0 (fi) -laktam-antibiotika, foerfarande foer deras framstaellning och deras anvaendning saosom laekemedel
GB1143082A (en) Fluorinated imidazopyridines
ES449141A1 (es) Procedimiento para la obtencion de penicilinas.
GB1040166A (en) Penicillins
SE7709646L (sv) Antibakteriella medel
GB1184665A (en) Penicillins
JPS5111782A (en) 77 aminosefuemujudotaino seizoho
ES451449A1 (es) Un procedimiento para la preparacion de nuevos derivados delacido 6-(d-2-acilamido-2-fenilacetamido)penicilanico.

Legal Events

Date Code Title Description
ST Notification of lapse